National Diabetes Act

National Diabetes Act - States that it is the purpose of this Act to expand the authority of the National Institute of Arthritis, Metabolism, and Digestive Diseases in order to advance the national attack on diabetes.

Authorizes the Director of the National Institute of Arthritis, Metabolism, and Digestive Disease, with the advice of the National Advisory Council of the Institute, to develop a plan for a national diabetes program. Sets forth general guidelines for such program and provides that the program shall be coordinated with the other programs conducted or administered by the research institutes of the National Institute of Health.

Provides that the plan required to be developed by this Act shall be developed within two hundred seventy days after the effective date of this Act.

Requires the Director of the Institute, at the end of each calendar year, to prepare and submit to the President for transmittal to the Congress a report on the activities, progress and accomplishments under the program during the preceding year and a plan for the program for the succeeding five-year period.

Authorizes the Director of the National Institute of Arthritis, Metabolism, and Digestive Diseases to establish programs as necessary in cooperation with other Federal health agencies, State, local, and regional public health agencies, and nonprofit private health agencies, in the prevention, control, and evaluation of diagnosis and treatment of diabetes, appropriately emphasizing the prevention, control, diagnosis and treatment of such diseases in children.

Authorizes to be appropriated $25,000,000 for the fiscal year ending June 30, 1974, $35,000,000 for the fiscal year ending June 30,1975, and $45,000,000 for the fiscal year ending June 30, 1976, for the purpose of establishing such programs.

States that the Director of the National Institute of Arthritis, Metabolism, and Digestive Diseases may provide for the development of not less than fifteen centers for basic and clinical research into, training in, and demonstration of advanced diagnostic, prevention, and treatment methods for diabetics. Outlines a diabetes prevention program for the centers.

States that support of such a center may be for a period of not to exceed five years and may be extended by the Director of the National Institute of Arthritis, Metabolism, and Digestive Diseases for additional periods of not more than five years each, after review of the operations of the center by a scientific review group established by the Director.

Establishes an Interagency Technical Committee on Diabetes which shall be responsible for coordinating those aspects of all Federal health programs and activities relating to diabetes.